GRCE vs GWW · $35.0M cap vs P/E 27, rev $9.76B
Grace Therapeutics, Inc. (GRCE) versus WW Grainger Inc (GWW) — a side-by-side from cached financials, not a winner call.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
GRCE does not have a complete income-statement cache yet.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
GRCE currently screens at market cap $35.0M. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Not investment advice. Open the GRCE and GWW stock pages for the full models.
Not investment advice.